The results of a clinical trial, run by Boston University with support from HE2RO, show that same-day initiation of antiretroviral therapy (ART) for HIV patients in South Africa led to a higher proportion of people starting treatment and to better health outcomes. The study was led by Sydney Rosen, a BU Research Professor and Director of HE2RO. A short video and further information can be seen here
Stay up to date
Receive newsletters and keep up to date with developments at HE2RO.